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Abstract. Adenoid cystic carcinoma (ACC) is a relatively rare 
tumor that accounts for <1% of all head and neck malignan-
cies. Laryngeal localization of ACC, which is most commonly 
hypoglottic, is relatively rare, occurring in 0.07-0.25% of all 
laryngeal tumors. ACC is characterized as a slow-growing 
tumor with a high recurrence rate, which often causes dyspnea 
and hoarseness. ACC exhibits a propensity for perineural 
invasion and thus, patients may experience pain as a late 
symptom of the disease. Distant metastasis occurs in 35-50% 
of cases and the lungs are the most common site of metastasis. 
Tumors are usually diagnosed by physical examination with 
fiberoscopy and computed tomography of the neck and chest, 
due to the high rate of lung metastases. The standard therapy 
for ACC is surgery followed by radiotherapy. In this study, 
a 70-year-old patient presented with laryngeal ACC, who 
underwent total laryngectomy with bilateral neck dissection 
and adjuvant radiotherapy, is presented. Follow-up examina-
tion performed 2 years after surgery revealed no evidence 
of locoregional recurrence or distant metastases. Previously 
published literature regarding ACC of the larynx was also 
reviewed.
Introduction
Adenoid cystic carcinoma (ACC) is a malignant neoplasm of 
the epithelium, which occurs in the major and minor salivary 
glands (1). In 1859, Billroth used the term ‘cylindroma’ to 
describe the standard histology of salivary gland tumors, 
however, this was replaced by the term ‘ACC’ in 1953 (2,3).
ACC is a relatively rare tumor, accounting for <1% of all 
head and neck malignancies and 7.5-10% of all salivary gland 
neoplasms (3-6).
Laryngeal localization of ACC, which is most frequently 
hypoglottic, is relatively rare, occurring in 0.07-0.25% of all 
laryngeal tumors (5,7,8). ACC tumors arise from submucosal 
minor salivary glands, in which laryngotracheal mucosa 
is sparse (5,9). The majority of the minor salivary glands 
are located in the subglottis (60%), however, they are also 
identified in the supraglottis, false vocal cords, aryepiglottic 
folds and caudal aspect of the epiglottis (5,7,10). Tumors of 
the minor salivary glands are usually malignant and ACC 
presents the most common tumor type (5,7). These tumors 
most frequently occur in the oral cavity, particularly in the 
hard palate, however, tumors are less common in the nasal 
cavity, paranasal sinuses, pharynx and larynx (5,11), due to 
the distribution of minor salivary glands in these regions. 
ACC most commonly occurs in patients aged between 50 and 
60 years old with no gender predilection (11). Laryngeal ACC 
is characterized as a slowly-growing tumor with symptoms 
that are dependent on the location of the tumor. For example, 
certain patients present with dyspnea, while patients with 
lesions that involve the true vocal cords present with hoarse-
ness and dysphagia that is associated with ear pain (12). 
Distant metastasis is observed in 35-50% of ACC cases and 
most commonly occurs in the lungs (2). Diagnostic modalities 
include physical examination with fiberoscopy and computed 
tomography of the neck and chest in order to identify lung 
metastases, which are extremely common (13). At present, 
surgery followed by radiotherapy is the standard treatment 
for ACC (10). Approximately 50% of ACC patients experi-
ence recurrence within 5 years of diagnosis, however, ACC 
exhibits a fairly good prognosis, with a 5-year overall survival 
rate of 70% (14).
To the best of our knowledge, in the last 15 years a total of 
81 cases of ACC of the larynx have been reported in the litera-
ture (Table I). In this study, a case of laryngeal ACC in a 
70-year-old man, which was a candidate for total laryngec-
tomy with bilateral neck dissection and adjuvant radiotherapy, 
is presented.
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Case report
In May 2012, a 70-year-old man presented to the Department 
of Otolaryngology-Head and Neck Surgery at ‘Federico II’ 
University (Naples, Italy) with ear pain, dysphonia, a 1-year 
history of dysphagia and a 1-month history of dyspnea. The 
patient was a former smoker (80 cigarettes/day for 50 years) 
and had previously been diagnosed with diabetes mellitus and 
chronic renal failure, which had been managed with dialysis 
for 10 years.
Laryngoscopy revealed a bulging mass in the left true vocal 
cord and left ventricle, which extended to the subglottic area 
with lack of mobility of the left larynx (Fig. 1). In the neck, 
left lymph nodes were palpable (level III). Total body posi-
tron emission tomography-computed tomography (PET-CT) 
with contrast medium revealed hyperaccumulation of tracer 
in the left laryngeal region (standardized uptake volume, 7.9) 
(Fig. 2). Magnetic resonance imaging (MRI) of the neck with 
contrast medium revealed asymmetric reduction of the laryn-
geal glottic plane and the presence of a solid, inhomogeneous 
lesion with evidence of increased perfusion predominantly in 
the left true vocal cord (28x37 mm).
This lesion laterally destroyed the paraglottic space, 
upward interesting the ipsilateral false vocal cord and ante-
riorly reaching the anterior commissure; posteriorly and 
inferiorly it was associated with mixed structural alteration 
mainly thickening of the left arytenoid cartilage, especially 
in his vocal process, and the posterosuperior and lateral 
portion of the cricoid cartilage, which exhibited moderate and 
uniform contrast enhancement suggesting infiltrative growth 
into nearby structures (Fig. 3). In addition, neck MRI revealed 
an enlarged left cervical lymph node, measuring 1.8 cm in 
diameter. Clinical staging was T3N1M0 (stage III, according 
to the Union for International Cancer Control/American Joint 
Committee on Cancer staging system) (38).
Biopsy of the tumor mass by direct microlaryngoscopy 
in suspension revealed a cellular neoplasm with prominent 
cribriform architecture, which was composed of small, bland 
hyperchromatic cells with a high nuclear-to-cytoplasmic ratio. 
The neoplastic cells surrounding the pseudoglandular spaces 
were filled with basement membrane‑like material and mucin 
(Fig. 4).
Subsequently, the patient underwent total laryngectomy 
with bilateral selective neck dissection (levels II-IV, left side; 
levels II-III, right side).
Tissue sections (3-5 µm) from each specimen were 
mounted on glass slides and dried overnight at 37°C. All 
sections were deparaffinized in xylene, rehydrated through 
a graded alcohol series and washed in phosphate-buffered 
saline. Tissue sections were processed using the standard 
streptavidin-biotin-immunoperoxidase method (Dako LSAB2 
Universal Kit; Dako, Carpinteria, CA, USA). Rabbit polyclonal 
anti-human c-kit antibody (CD117; catalog no. 34-8800; Dako) 
at 1:50 dilution was used according to the manufacturer's 
protocols. Hematoxylin and eosin (Sigma-Aldrich; Merck 
KGaA, Damrstadt, Germany) stain was used as the final 
chromogen. Histological examination identified the presence 
of ACC, which exhibited focal solid areas and infiltration 
of the cartilage and fibroadipose perilaryngeal tissues with 
perineural invasion. All dissected neck lymph nodes were 
Figure 3. Neck magnetic resonance imaging with contrast medium revealed 
asymmetric reduction of the laryngeal glottic plane due to the presence of 
a solid, inhomogeneous lesion. Increased perfusion was observed predomi-
nantly in the left true vocal cord (28x37 mm).
Figure 2. Total body positron emission tomography-computed tomography 
with contrast medium revealed hyperaccumulation of tracer in the left laryn-
geal region (standardized uptake volume, 7.9).
Figure 1. Laryngoscopy revealed a bulging mass in the left true vocal cord 
and left ventricle extending to the subglottic area with fixity of the left larynx.
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Table I. Previous case reports of adenoid cystic carcinoma arising in the larynx reported in the English language literature over 
the last 15 years.
   Recurrence sites
   (local-regional/
First author/s, year Case(s), n Primary tumor localization distant metastases) Survival Ref.
Javadi et al, 2002 1 Subglottis ND ND (1)
Saraydaroglu et al, 2011 1 Supraglottis-glottis ND ND (5)
Ganly et al, 2006 12 Larynx ND ND (7)
Lee et al, 2003 1 Larynx ND ND (15)
Del Negro et al, 2007 1 Subglottis ND ND (16) 
Amit et al, 2014 6 Larynx ND NED - Follow-up (17)
    period 3-288 months 
    (median, 64 months) 
Qian et al, 2014 1 Supraglottis Regional recurrence NED-42 months (18)
   [supraglottis, glottis  follow-up 
   and subglottis (1 cm)]  
Misiukiewicz et al, 2013 1 Transglottic Distant metastases  Alive, 112 months (19)
   (pulmonary metastases at  follow-up 
   54 months) 
 1 Glottis None NED - 60 months 
    follow-up 
Testa et al, 2013 1 Glottis-subglottis ND NED - 36 months (20)
    follow-up 
Murray et al, 2010 1 Larynx Lung metastasis and ND (21) 
   splenic lesion  
Zvrko and Golubović, 1 Subglottis ND NED ‑ 6 months  (22)
2009    follow-up 
Wang et al, 2009 1 Subglottis ND NED - 6 months (23)
    follow-up 
Zeng et al, 2009 10 Supraglottis/Subglottis ND ND (24)
Maukarbel et al, 2008 15 Supraglottis (2; 13.3%), Distant metastases (7), 6 patients alive (25)
  glottis (1; 6.6%), local/distant (2), (1 NED), 9 patients 
  subglottis (9; 60%) and local residual (1), succumbed (7 from 
  transglottis (3; 20%) none (3) and their disease. 6.9 years 
   regional (2) follow-up (range, 
    1.3-22.3 years) 
Aydin et al, 2008 1 Subglottis None NED - 6 years (26)
Messaoudi et al, 2007 1 Subglottis None NED - 6 months (27)
Khan et al, 2006 1 Subglottis ND ND (28)
Pino Rivero et al, 2006 1 Larynx Pulmonary metastases NED - 1 year (29)
Natarajan et al, 2004 1 Larynx ND ND (30)
Adachi et al, 2003 1 Larynx Choroidal/optic disc ND (31) 
   metastasis  
Dexemple et al, 2003 2 Larynx ND ND (32)
Mahlstedt et al, 2002 6 Larynx ND ND (33)
Issing et al, 2002 3 Larynx ND ND (34)
Altaf, 2001 1 Larynx ND ND (35)
Szmeja et al, 2001 1 Larynx ND ND (36)
Lucioni et al, 2015 8 Supraglottis (2), Regional metastases (2) NED - 41 months (37)
  transglottis (1) and  median follow-up  
  subglottis (5)  (range, 14-301  
    months) 
NED, no evidence of disease; ND, not determined.
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free of metastases. Immunohistochemical analysis of ACC 
cells revealed positivity for the c-kit protein. Subsequently, the 
tumor was pathologically staged as ACC T3N0M0 (stage III).
The patient was administered adjuvant radiotherapy 
(66 Gy) for 6 weeks according to recent guidelines (39). 
Follow-up examinations were performed every 6 months and 
follow-up 2 years after surgery revealed no evidence of locore-
gional recurrence or distant metastases.
Discussion
ACC of the larynx most commonly occurs in patients aged 
between 40 and 60 years-old (5,11,15). However, in the present 
case, ACC of the larynx was diagnosed in a 70-year-old 
patient. In the last 15 years, a total of 81 laryngeal ACCs 
have been reported and well-documented in the English 
literature (Table I). ACC is the predominant histological 
type among malignancies of the minor salivary glands, with 
a frequency of 10-20%, representing only 2-4% of all head 
and neck malignancies. ACC of the larynx is incredibly rare 
(0.07-0.25% of all laryngeal tumours, 1% of all ACC) as there 
are few salivary glands in the mucosa of laryngeal-tracheal 
tract (5). These tumors are predominantly subglottic (64%), 
such as in the present case. Moreover, their prevalence is 
25% for the supra-glottic region, 5% for the glottic region and 
6% for the trans-glottic area. This pattern of distribution in 
the anatomical laryngeal subsites is due to their origin from 
submucosal glands, which are more frequently found in the 
subglottic region of the larynx (1,5,7,15,16-37). These tumors 
grow slowly with perineural diffusion (37). So the evolution 
prognosis of this disease is caused by lung, bone and brain 
metastases or by local recurrence (20,37).
ACC of the larynx develops in a similar manner to ACC of 
other head and neck sites. It is considered a slowly growing but 
highly invasive cancer with a high recurrence rate.
In the laryngeal region, symptoms depend on the tumor 
location. Patients with subglottic cancer show dyspnea, whereas 
common symptoms of glottis implications are dyspnea and a 
hoarse voice. Subglottic tumors are rare and associated with 
stridor and airway obstruction (12). In the present clinical case, 
an initial glottic and supraglottic lesion infiltrating the left true 
vocal cord and left ventricle caused hoarseness (due to vocal 
cord compromise) and dysphagia associated with ear pain for 
1 year (10), and subsequently, the major extension of the lesion 
to the subglottic region resulted in dyspnea (due to airway 
obstruction) over the last month.
In the present case, physical and radiological examina-
tions identified an enlarged left cervical lymph node, 1.8 cm 
in diameter with no evidence of distant metastasis. Previously 
it has been reported that nodal metastasis is a common cause 
of treatment failure in ACC patients (16), however, metastasis 
to the cervical lymph nodes is rare in ACC, occurring in 
10-20% of patients with head and neck ACC (38). Notably, 
the metastasis rates of ACC located in the base of the tongue 
(19.2%), mobile tongue (17.6%) and mouth floor (15.3%) are 
higher than that of ACC of the larynx (15). In addition, clin-
ical investigations have shown that the incidence of ACC with 
distant metastasis ranges from 35 to 50%, and leads to 5-year 
survival rates ranging from 12-17% following surgery (12). 
The lungs are the most common site of distant metastasis 
from ACC (15).
We recommend that neck dissection is performed in all 
ACC patients with pre-operative evidence of nodal metastases, 
as indicated by physical examination and imaging studies 
including CT, MRI and/or PET-CT, since occult cervical 
metastases of head and neck ACC occurs in 10-20% of 
cases (38).
The prognostic factors of ACC are dependent on tumor site, 
tumor stage and microscopic tumor pattern. Other prognostic 
factors are an age >60 years, a solid histological subtype, 
an advanced clinical stage and the presence of perineural 
invasion (5,40).
In the patient of the present case, the ACC tumor was 
mainly localized to the glottis and supraglottic area, causing 
hoarseness and dysphagia; however, major extension of the 
lesion to the subglottic region resulted in dyspnea leading 
to a late diagnosis. In the larynx, tumor occurrence in the 
minor salivary glands is rare, accounting for <1% laryngeal 
tumors (5). The tumors arise from submucosal minor salivary 
glands, which exhibit a distinct anatomical distribution in the 
larynx. The majority of minor salivary glands are concen-
trated in the subglottis, however, they may also be identified 
in the supraglottis in the false vocal cords, aryepiglottic folds 
and caudal aspect of the epiglottis (5). The anatomical site in 
which laryngeal submucosal minor salivary glands are located 
explains the evolution of the symptoms in the present clinical 
case.
The patient in the present case was initially diagnosed with 
clinical stage III (cT3N1M0) disease, as tumor extension to 
the vocal cords with emilaryngeal lack of mobility (T3) and 
a metastatic omolateral lymph node (N1) were observed with 
no evidence of distant metastases (M0) (5). Tumor staging 
was postoperatively confirmed as T3N0M0 since all dissected 
neck lymph nodes were free of metastases.
According to the World Health Organization Clas-
sification of Tumors (41), ACC may be divided into three 
microscopic grades: Tubular (well-differentiated/grade I), 
which exhibits the best prognosis; cribriform (moder-
ately-differentiated/grade II), which is the most common; 
and solid (poorly-differentiated/grade III), which is the least 
common with the worst prognosis (5,16,17). ACC tumors often 
exhibit a mixture of the three histological growth patterns 
and thus, tumors are classified according to the predomi-
nant pattern (42). The tumor in the present case exhibited a 
Figure 4. Hematoxylin/eosin staining of an adenoid cystic carcinoma. 
Magnification, x10.
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classic cribriform pattern and thus was defined as low‑grade 
(grade II).
Generally, neoplastic ACC cells exhibit myoepithelial and 
ductal differentiation, with positivity for p63, S100 protein, 
smooth muscle actin and cytokeratins (43). Typically, the most 
peripheral cells of the tumor nests and glands are arranged 
in a cribriform pattern and exhibit myoepithelial differen-
tiation that is accompanied by the abundant production of 
extracellular matrix and basement membrane components, 
such as laminin (43). Loss of laminin or reduced expres-
sion may occur during transformation to a more aggressive 
malignancy (3,44). In the present case, immunochemistry 
revealed positivity for c-kit protein, a class III transmem-
brane receptor tyrosine kinase. C-kit is a proto-oncogene 
encoded by a gene located on the human chromosome 
segment 4q11, which leads to activation of specific intra-
cellular signal transduction cascades that contribute to the 
cellular growth and differentiation that subsequently confers 
a worse prognosis (11). Thus, further investigation is required 
to characterize c-kit functional pathways in salivary gland 
tumors and to evaluate potential therapeutic effects of small 
molecule inhibitors of c-kit, such as imatinib mesylate (42). 
In ACC, c-kit expression is limited to the inner epithelial 
cells, whereas epidermal growth factor receptor (EGFR) 
is typically expressed in myoepithelial cells. EGFR, which 
facilitates carcinogenesis in humans via the blockade of 
apoptosis and promotion of angiogenesis, may be modified 
by anti-EGFR agents, including cetuximab and erlotinib. In 
addition, recent studies have reported that cytogenetically, 
ACC is characterized by the tumor‑type specific transloca-
tion, t(6;9) (q22‑23;p23‑24), which has been identified as the 
sole anomaly in certain cases. This traslocation results in 
the fusion of the MYB proto-oncogene and the transcription 
factor gene nuclear factor I-B (NFIB), leading to the forma-
tion of the MYB-NFIB fusion oncogene, which is highly 
overexpressed in ACC; thus, it may be considered a useful 
biomarker for the disease (3,11).
At present, surgery followed by radiotherapy is the stan-
dard treatment for ACC due to the risk of perineural and 
hematogenous spread. According to the literature, surgical 
excision of the lesion is recommended due to the relative 
radioresistance of these tumors. Surgical excision should be 
performed with bilateral selective neck dissection in cases 
where frozen sections reveal negative lymph nodes (no 
tumoral infiltration) (pN0) and with radical neck dissection 
in cases whereby frozen sections reveal positive lymph nodes 
(pN+) (39).
The patient in the present case underwent total laryngec-
tomy associated with bilateral selective neck dissection (levels 
II-IV, left side; levels II-III, right side). Furthermore, frozen 
biopsy sections revealed that negative lymph nodes were 
negative for metastasis (pN0) and thus adjuvant radiotherapy 
(66 Gy) was administered according to recent guidelines (39).
Postoperative radiation is recommended in certain cases, 
as radiotherapy has been demonstrated to result in tumor 
regression and symptomatic relief (16). However, the use of 
chemotherapy for ACC remains controversial. Certain studies 
have demonstrated positive patient responses to chemotherapy 
and thus, it is recommended as palliative therapy in advanced 
cases (5,17).
However, currently, the identification of molecular abnor-
malities underlying ACC, such as those of c-kit and EGFR, is 
paramount for the development of specific targeted therapies.
Previous case reports of ACC in the larynx during the last 
14 years are listed in Table I (1,5,7,15-37). 
After 2 years of post-operative follow-up, performed every 
6 months, the patient in the current study remained free of 
locoregional recurrence and/or distant metastases.
In conclusion, ACC is a relatively rare tumor comprising 
<1% of all malignancies of the head and neck area. ACC of 
the larynx occurs more commonly in middle-aged or older 
patients, evolving slowly and with patients mainly devel-
oping dyspnea. In addition, it is considered a highly invasive 
cancer with a high recurrence rate and an incidence of distant 
metastasis ranging from 35 to 50%, resulting in a low long-
term survival rate (12). It has been well-documented that 
the most common site of distant metastasis from ACC is the 
lung. In localized ACC, the gold-standard therapy is surgery 
followed by adjuvant radiotherapy. Novel therapeutic frontiers 
will focus on the identification of molecular abnormalities 
underlying ACC, such as c‑kit and EGFR, to develop specific 
targeted therapies.
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